Performance evaluation of a combination Plasmodium dual-antigen CRP rapid diagnostic test in Lambaréné, Gabon
S-DUO RDT is suitable for malaria detection in moderate-to-high malaria transmission settings such as in Lambaréné; however, a CRP band detection limit > 40 mg/L is more adequate for indication of antibiotic prescription for AFI cases in Gabon.
Authors
- Michael Ramharter (ORCID: https://orcid.org/0000-0002-9259-1885)
- Fabrice Lotola-Mougeni
- Maria Yazdanbakhsh (ORCID: https://orcid.org/0000-0002-7666-1441)
- Anita Lumeka Kabwende
- Victoria Harris (ORCID: https://orcid.org/0000-0002-9117-0114)
- B. Leticia Fernández-Carballo
- Peter G. Kremsner (ORCID: https://orcid.org/0000-0002-3926-4113)
- Aurélien Macé (ORCID: https://orcid.org/0000-0002-3282-1650)
- Camille Escadafal (ORCID: https://orcid.org/0000-0002-0268-750X)
- Paulin N. Essone (ORCID: https://orcid.org/0000-0003-4110-0596)
- Ayodele Kamal ALABI (ORCID: https://orcid.org/0000-0002-2121-6631)
- Kristin Murphy (ORCID: https://orcid.org/0000-0002-3057-0122)
- Sabine Dittrich (ORCID: https://orcid.org/0000-0002-4522-2788)
- Sélidji Todagbé Agnandji (ORCID: https://orcid.org/0000-0003-4693-4207)
- Saïdou Mahmoudou (ORCID: https://orcid.org/0009-0007-6476-4068)
- Fungai P. Musangomunei
- Juste C. Bie-Ondo
- Martin P. Grobusch
Institutions
- FIND (CH)
- Universität Hamburg (DE)
- Leiden University Medical Center (NL)
- University of Oxford (GB)
- London School of Hygiene & Tropical Medicine (GB)
- Universitätsklinikum Tübingen (DE)
- Centre de Recherche Médicales de Lambaréné (GA)
- University Hospital Münster (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Amsterdam University Medical Centers (NL)
- Deggendorf Institute of Technology (DE)
- University of Amsterdam (NL)
- Bernhard Nocht Institute for Tropical Medicine (DE)
Publication Details
- Journal
- Infection
- Published
- 2024-08-23
- DOI
- https://doi.org/10.1007/s15010-024-02366-y
- Citations
- 1
- Primary Topic
- Malaria Research and Control
- Type
- article
- Field-Weighted Citation Impact
- 0.54
Funders
- Johns Hopkins University
- Universitätsklinikum Tübingen
- European and Developing Countries Clinical Trials Partnership